These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33616870)

  • 1. Nanomedicines in the treatment of colon cancer: a focus on metallodrugs.
    Farinha P; Pinho JO; Matias M; Gaspar MM
    Drug Deliv Transl Res; 2022 Jan; 12(1):49-66. PubMed ID: 33616870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallodrugs in cancer nanomedicine.
    Peña Q; Wang A; Zaremba O; Shi Y; Scheeren HW; Metselaar JM; Kiessling F; Pallares RM; Wuttke S; Lammers T
    Chem Soc Rev; 2022 Apr; 51(7):2544-2582. PubMed ID: 35262108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-targeted nanomedicines for cancer theranostics.
    Arranja AG; Pathak V; Lammers T; Shi Y
    Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From metallodrugs to metallodendrimers for nanotherapy in oncology: a concise overview.
    El Kazzouli S; El Brahmi N; Mignani S; Bousmina M; Zablocka M; Majoral JP
    Curr Med Chem; 2012; 19(29):4995-5010. PubMed ID: 22963626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial nanomedicines for colon cancer therapy.
    Anitha A; Maya S; Sivaram AJ; Mony U; Jayakumar R
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(1):151-9. PubMed ID: 26061225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold (III) Derivatives in Colon Cancer Treatment.
    Gurba A; Taciak P; Sacharczuk M; Młynarczuk-Biały I; Bujalska-Zadrożny M; Fichna J
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal Formulations of Metallodrugs for Cancer Therapy.
    Botter E; Caligiuri I; Rizzolio F; Visentin F; Scattolin T
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold Complexes in Anticancer Therapy: From New Design Principles to Particle-Based Delivery Systems.
    Moreno-Alcántar G; Picchetti P; Casini A
    Angew Chem Int Ed Engl; 2023 May; 62(22):e202218000. PubMed ID: 36847211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal Formulations of a New Zinc(II) Complex Exhibiting High Therapeutic Potential in a Murine Colon Cancer Model.
    Ribeiro N; Albino M; Ferreira A; Escrevente C; Barral DC; Pessoa JC; Reis CP; Gaspar MM; Correia I
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for the Nuclear Delivery of Metal Complexes to Cancer Cells.
    Huynh M; Vinck R; Gibert B; Gasser G
    Adv Mater; 2024 Apr; 36(16):e2311437. PubMed ID: 38174785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presenting a bioactive nanotherapeutic agent for colon cancer treatment.
    Hassanzadeh P; Arbabi E
    Eur J Pharmacol; 2022 Jul; 927():175084. PubMed ID: 35679890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-based drug delivery systems for cancer treatment.
    Arias JL; Clares B; Morales ME; Gallardo V; Ruiz MA
    Curr Drug Targets; 2011 Jul; 12(8):1151-65. PubMed ID: 21443475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment.
    Kwon S; Ko H; You DG; Kataoka K; Park JH
    Acc Chem Res; 2019 Jul; 52(7):1771-1782. PubMed ID: 31241894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of a copper complex loaded in pH-sensitive long circulating liposomes for colon cancer management.
    Pinho JO; da Silva IV; Amaral JD; Rodrigues CMP; Casini A; Soveral G; Gaspar MM
    Int J Pharm; 2021 Apr; 599():120463. PubMed ID: 33711474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review.
    Fathi-Karkan S; Arshad R; Rahdar A; Ramezani A; Behzadmehr R; Ghotekar S; Pandey S
    Eur J Med Chem; 2023 Nov; 259():115676. PubMed ID: 37499287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioanalytical strategies to evaluate cisplatin nanodelivery systems: From synthesis to incorporation in individual cells and biological response.
    Gutierrez-Romero L; Díez P; Montes-Bayón M
    J Pharm Biomed Anal; 2024 Jan; 237():115760. PubMed ID: 37839264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current trends and future perspectives of nanomedicine for the management of colon cancer.
    Wahab S; Alshahrani MY; Ahmad MF; Abbas H
    Eur J Pharmacol; 2021 Nov; 910():174464. PubMed ID: 34474029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers.
    Yang J; Wang X; Wang B; Park K; Wooley K; Zhang S
    Adv Drug Deliv Rev; 2022 Nov; 190():114525. PubMed ID: 36100142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.